1. Introduction {#s0005}
===============

Adults with medical multimorbidity, usually defined as ≥2 concurrent chronic conditions ([@bb0050]; [@bb0180]), have high rates of healthcare utilization and associated costs ([@bb0085]; [@bb0090]). In addition to often receiving poorly coordinated care ([@bb0025]), people with medical multimorbidity experience the consequences associated with having multiple chronic conditions including adverse effects from treatments or interventions, disability, and death ([@bb0005]). In addition, living with medical multimorbidity often includes taking multiple prescribed medications and careful monitoring of individual diseases. Substance use can have profound negative effects on chronic diseases, therefore drug use and substance use disorder (SUD) must be considered when developing effective care for the increasing number of adults with medical multimorbidity ([@bb0120]).

Use of various psychoactive drugs is associated with a wide range of physiologic effects that can affect the cardiovascular, gastrointestinal, hematological, pulmonary, and neurological systems, and therefore influence existing chronic disease and complicate management ([@bb0035]). SUDs themselves are considered chronic diseases with known physiological changes in the brain and need ongoing treatment and relapse prevention ([@bb0065]). Therefore, the interaction of substance use with chronic medical disease can lead to poor treatment outcomes for both SUDs and chronic medical conditions.

Many adults who are in treatment for SUD receive fragmented medical care for their other chronic conditions ([@bb0060]), and unhealthy substance use often goes undiagnosed and unrecognized by primary care physicians ([@bb0145]). The ability to manage chronic diseases depends on the awareness of substance use and its possible effects on chronic medical diseases. However, few studies have focused on the intersection of chronic medical disease and drug use, and there are no studies that estimate the prevalence of drug use among adults with multiple chronic conditions. Therefore, the objective for this study was to use cross-sectional data from a nationally representative sample of adults in the United States (US) to estimate the prevalence of drug use among adults with chronic medical diseases, and to determine demographic and behavioral correlates of drug use among adults with medical multimorbidity.

2. Methods {#s0010}
==========

2.1. Data source and study sample {#s0015}
---------------------------------

This study aggregated data from three cohorts (years 2012, 2013, and 2014) of the National Survey on Drug Use and Health (NSDUH), an annual cross-sectional survey of individuals in the US ([@bb0175]). A different cross-section of non-institutionalized respondents is sampled each year and therefore each cohort is independent of each other. NSDUH is a nationally representative sample of individuals living in the US (all fifty US states and the District of Columbia) and the sample was achieved by the following methods: census tracts were first chosen within each state, then sections in each tract were selected, then households, and then respondents were selected for the sample each year. Surveys were administered through computer-assisted interviewing---conducted by an interviewer and audio computer-assisted self-interviewing (ACASI). Sampling weights were provided by NSDUH to address individual and unit-level non-response. Weights were adjusted to ensure that approximations are consistent with estimates provided by the US Census Bureau. Detailed information regarding the NSDUH survey and its sampling methods can be found elsewhere ([@bb0175]). The weighted interview response rates for NSDUH years 2012 through 2014 was 71.7--73.0%, and missing or incomplete data were revised by imputation.

2.2. Definitions {#s0020}
----------------

The NSDUH survey asks respondents if they had ever been informed by a doctor or other medical professional that they have ever had the following 12 medical diseases: asthma, bronchitis, cirrhosis of the liver, diabetes, heart disease, hepatitis, hypertension (high blood pressure), lung cancer, HIV/AIDS, sleep apnea, stroke, and ulcers. These medical diseases are frequently considered chronic medical conditions, and are included in either the validated Katz chronic disease comorbidity questionnaire ([@bb0075])^15^ or the Hierarchical Condition Category system ([@bb0135]) and obstructive sleep apnea, which is recognized as one of the most prevalent chronic respiratory disorders ([@bb0080]) and therefore included in our analysis. Medical multimorbidity is defined in the literature as 2 or more chronic diseases ([@bb0050]; [@bb0180]). Using the above conditions to study medical multimorbidity (≥2 chronic conditions) with the NSDUH has been performed in other studies ([@bb0165]).

Drug use was assessed by NSDUH by self-report of cannabis (marijuana and hashish), cocaine (including crack), heroin, inhalants, hallucinogens, and nonmedical use of prescription medications (including opioids, tranquilizers, stimulants, and sedatives). Nonmedical use of prescription medications was defined as use of a drug that was not prescribed or used for the experience or feeling it caused. Nicotine dependence was defined based on dependence criteria of the Nicotine Dependence Syndrome Scale (NDSS) ([@bb0160]) and alcohol dependence was defined by the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) ([@bb0010]). SUDs were determined by participant responses to a series of questions that determined if criteria would meet DSM-IV abuse or dependence ([@bb0010]) categories for each drug. While NSDUH is not a diagnostic interview, this method provided a proxy diagnosis.

2.3. Statistical analyses {#s0025}
-------------------------

Analyses include all respondents aged 18 and older. We aggregated data from the three separate cohort years into a single cross-section to be able to increase power for examining associations between variables with low prevalence (i.e., use of various drugs among those with multimorbidity). We first examined bivariable associations between demographic characteristics and number of self-reported conditions (i.e., 0, 1, ≥2). Demographic measures included age (i.e., 18--34, 35--49, 50--64, and ≥65), sex, race/ethnicity (i.e., non-Hispanic white, African American, Asian, Hispanic of any race, and other), education level (i.e., \<high school, high school, some college, college or more), total family income (i.e., \<\$20,000, \$20,000--\$49,999, \$50,000--\$74,000, ≥\$75,000), marital status (i.e., married, widowed, divorced or separated, never married). NSDUH only provides pre-coded categorical responses for the age and income variables, and therefore could not be analyzed as a continuous variable. Tobacco use (past month, year), nicotine dependence, alcohol use (past month, year), alcohol dependence, self-reported overall health (i.e., excellent, very good, good, fair), and self-reported mental health problems in the past-year (i.e., major depressive episode based on DSM IV criteria, self-reported anxiety, respondents who received mental health treatment) were also compared among adults reporting 0, 1, and ≥2 chronic conditions.

Bivariable analyses was also performed comparing past-year drug use and diagnosed substance use disorder for adults with 0, 1, and ≥2 chronic conditions. We evaluated correlates of past-year drug use among adults with medical multimorbidity using binary logistic regression. We first estimated odds of each covariate separately, generating unadjusted odds ratios (ORs). We then fit covariates simultaneously using multiple logistic regression. The adjusted ORs (AORs) represent the odds of each category with all else in the model being equal. All analyses were weighted as part of NSDUH to account for the complex survey design and to obtain accurate standard errors for estimates at the population level. More detailed information regarding the development of analysis weights are found elsewhere ([@bb0030]). Since our analyses utilized data from 3 cohorts, we divided the weights by 3 to obtain nationally representative estimates. Stata SE 13 ([@bb0170]) was used for all analyses, and survey ("svy") commands were utilized to provide accurate standard errors using Taylor series estimation methods ([@bb0070]). Secondary analysis of this publically available data was exempt for review by the New York University Langone Medical Center Institutional Review Board.

3. Results {#s0030}
==========

The analytic sample included 115,335 respondents. Chronic medical conditions were common among respondents with weighted percentages of 29.5% of adults reporting 1 chronic condition and 17.4% reporting 2 or more conditions, and therefore 46.9% reported at least 1 chronic condition and 53.1% reported no chronic conditions ([Table 1](#t0005){ref-type="table"}). Most adults with medical multimorbidity were middle-aged (50--64 years of age) and older adults (≥65 years old), while younger adults (18--34 years of age) were more likely to report no chronic conditions (*p* \< 0.001). Compared with adults reporting no chronic conditions, adults with medical multimorbidity were also more likely to be non-Hispanic white, less educated, married, have nicotine dependence, drink alcohol less frequently, report having worse health status, and more likely to have depression, anxiety, and need mental health treatment in the past year (*p* \< 0.001 for all comparisons).Table 1Sample characteristics by number of chronic conditions, % (n) -- United States 2012--2014[a](#tf0005){ref-type="table-fn"}.Table 1Number of chronic conditions0 chronic conditions1 chronic condition≥2 chronic conditions*p*-Valuen% (95% CI)n% (95% CI)n% (95% CI)Characteristic72,34153.1% (52.6, 53.7)29,41929.5% (29.0, 30.0)13,57517.4% (17.0, 17.8)Age group\
(years of age) 18--3449,31841.3 (40.6, 42.0)14,63421.9 (21.3, 22.5)408310.7 (10.2, 11.2)\<0.001 35--4915,36528.9 (28.4, 29.5)705123.6 (22.8, 24.4)340618.3 (17.5, 19.1)\<0.001 50--64543520.6 (19.9, 21.4)445029.8 (28.8, 30.9)321535.1 (33.7, 36.4)\<0.001 ≥6522239.1 (8.7, 9.6)328424.7 (23.8, 25.6)287136.0 (34.6, 37.3)\<0.001Sex Male33,97548.0 (47.4, 48.5)13,47048.6 (47.8, 49.4)589947.0 (45.7, 48.4)0.12 Female38,36652.0 (51.5, 52.6)15,94951.4 (50.6, 52.2)767653.0 (51.6, 54.3)0.12Race/ethnicity Non-Hispanic White43,30162.5 (61.8, 63.2)18,89467.8 (66.6, 69.0)956574.0 (72.7, 75.2)\<0.001 Non-Hispanic African American846810.5 (10.0, 11.0)423613.8 (13.0, 14.6)162411.6 (10.6, 12.6)\<0.001 Hispanic13,37018.4 (17.9, 19.0)389812.2 (11.5, 12.9)13048.9 (8.2, 9.7)\<0.001 Non-Hispanic Asian37106.4 (6.0, 6.8)8793.7 (3.2, 4.3)3133.0 (2.4, 3.6)\<0.001 Other34922.2 (2.0, 2.3)15122.6 (2.3, 2.8)7692.6 (2.3, 3.0)\<0.001Education \<High school10,60213.4 (13.0, 13.9)425114.0 (13.4, 14.7)192013.2 (12.3, 14.0)\<0.001 High school22,37027.8 (27.2, 28.3)941831.1 (30.3, 32.0)435931.0 (30.0, 32.1)\<0.001 Some college21,58427.3 (26.7, 27.8)864525.9 (25.1, 26.7)393628.0 (26.9, 29.1)\<0.001 College or more17,78531.6 (30.9, 32.3)710528.9 (28.0, 29.9)336027.8 (26.7, 28.9)\<0.001Total family income \<\$20,00042,61544.5 (43.8, 45.2)15,85141.6 (40.7, 42.6)685442.3 (41.2, 43.5)\<0.001 \$20--\$49,99919,43931.8 (31.2, 32.4)853534.0 (33.0, 35.0)426334.7 (33.5, 36.0)\<0.001 \$50,000--\$74,999534511.5 (11.1, 12.0)259611.4 (10.8, 12.1)126011.1 (10.4, 11.9)\<0.001 ≥\$75,000494212.2 (11.6, 12.8)243713.0 (12.3, 13.7)119811.8 (11.0, 12.7)\<0.001Marital status Married25,04549.8 (49.1, 50.4)11,87154.5 (53.6, 55.5)636356.2 (54.8, 57.6)\<0.001 Widowed10073.4 (3.1, 3.6)12188.0 (7.5, 8.6)95210.5 (9.7, 11.4)\<0.001 Divorced or separated601912.5 (12.1, 12.9)344715.1 (14.5, 15.8)229418.4 (17.6, 19.4)\<0.001 Never married40,27034.4 (33.8, 35.0)12,88322.3 (21.7, 23.0)396614.8 (14.0, 15.7)\<0.001Tobacco use Past month use24,71529.4 (28.8, 30.1)966726.5 (25.8, 27.3)417524.4 (23.4, 25.4)\<0.001 Past year use30,52435.5 (34.9, 36.1)11,66331.2 (30.4, 32.1)488727.9 (26.8, 29.0)\<0.001 Past year nicotine dependence[b](#tf0010){ref-type="table-fn"}69978.6 (8.3, 9.0)31258.6 (8.2, 9.1)176010.2 (9.6, 10.9)\<0.001Alcohol use Past month use43,74260.0 (59.3, 60.7)17,18055.3 (54.4, 56.3)702648.4 (47.1, 49.6)\<0.001 Past year use55,11074.1 (73.5, 74.8)21,80669.6 (68.6, 70.5)932763.6 (62.2, 65.0)\<0.001 Past year alcohol Use, but not dependence51,82670.7 (70.1, 71.4)20,48366.2 (65.2, 67.1)874160.7 (59.3, 62.1)\<0.001 Past year alcohol dependence[c](#tf0015){ref-type="table-fn"}32843.4 (3.2, 3.6)13233.4 (3.1, 3.7)5662.9 (2.6, 3.3)\<0.001Overall Health Excellent21,59030.1 (29.5, 30.7)514115.6 (14.9, 16.3)11027.0 (6.4, 7.6)\<0.001 Very good29,47939.2 (38.7, 39.7)11,39537.0 (36.1, 37.8)377226.2 (25.0, 27.4)\<0.001 Good16,79323.3 (22.8, 23.9)905532.1 (31.3, 33.0)487536.8 (35.6, 38.0)\<0.001 Fair/poor44677.3 (7.0, 7.6)382015.3 (14.6, 16.1)382130.0 (28.9, 31.2)\<0.001Mental health Past year major depressive episode[c](#tf0015){ref-type="table-fn"}48945.7 (5.5, 6.0)25306.5 (6.1, 7.0)187810.9 (10.2, 11.6)\<0.001 Past year anxiety45115.7 (5.4, 5.9)22726.0 (5.6, 6.4)180710.4 (9.7, 11.1)\<0.001 Received mental health treatment in past year867212.0 (11.6, 12.4)481115.3 (14.7, 15.9)352123.1 (22.0, 24.2)\<0.001[^1][^2][^3]

[Table 2](#t0010){ref-type="table"} presents frequencies and weighted percentages of specific drugs used by 0, 1 or ≥2 chronic conditions. Overall, 16.1% of the full study sample reported past-year use of an illegal drug or cannabis and 2.6% reported meeting criteria for a SUD. The most common drug used in the past-year was cannabis, and cannabis use disorder was the most common SUD. Nonmedical use of opioid analgesics was the next-most common and opioid-related SUD was the second most common SUD. Among all adults with chronic conditions, past-year drug use was reported by 14.8% with 1 chronic condition and 11.6% with ≥2 conditions, and drug use was considerably higher among adults with no chronic conditions (18.3%) (*p* \< 0.001 for all comparisons). Among adults reporting no chronic conditions, 5.5% used ≥2 drugs, while 4.3% of adults with 1 chronic disease and 3.2% of adults with ≥2 chronic diseases reported use of \>1 drug in the past year (*p* \< 0.001). Criteria for past-year SUD was met by 2.4% with 1 chronic condition and 2.1% with ≥2 conditions, and 2.9% of adults with no chronic conditions (*p* \< 0.001).Table 2Past-year drug use by number of chronic conditions, % (n) -- United States 2012--2014[a](#tf0020){ref-type="table-fn"}.Table 2Number of chronic conditions0 chronic conditions (n = 72,341)1 chronic condition (n = 29,419)≥2 chronic conditions (n = 13,575)*p*-Valuen% (95% CI)n% (95% CI)n% (95% CI)Drug use category (past-year use) Any drug18,41918.3 (17.9, 18.8)666314.8 (14.2, 15.4)244811.6 (10.8, 12.4)\<0.001 Any drug, excluding cannabis83608.5 (8.2, 8.9)32167.3 (6.9, 7.7)12405.8 (5.3, 6.4)\<0.001 Cannabis15,72214.9 (14.5, 15.2)544611.2 (10.7, 11.8)19098.4 (7.8, 9.0)\<0.001 Cocaine21012.1 (2.0, 2.3)7581.7 (1.5, 1.9)2661.2 (1.0, 1.4)\<0.001 Heroin3710.3 (0.3, 0.4)1450.3 (0.2, 0.3)760.3 (0.2, 0.4)\<0.001 Opioid analgesics43594.6 (4.4, 4.8)17584.1 (3.8, 4.4)7643.4 (3.1, 3.8)\<0.001 Hallucinogens26072.1 (2.0, 2.3)7881.3 (1.1, 1.5)2630.7 (0.6, 0.9)\<0.001 Tranquilizers/sedatives22432.3 (2.2, 2.5)9762.3 (2.1, 2.6)4672.1 (1.8, 2.4)0.36 Stimulants15871.5 (1.3, 1.6)5581.0 (0.9, 1.1)2140.8 (0.7, 1.1)\<0.001 ≥2 illegal drug use60065.5 (5.3, 5.8)21964.3 (4.1, 4.6)8043.2 (2.8, 3.6)\<0.001Substance use disorder (past-year) Any drug32082.9 (2.7, 3.1)12792.4 (2.2, 2.7)5092.1 (1.8, 2.4)\<0.001 Any drug, excluding cannabis13991.4 (1.3, 1.6)6121.4 (1.2, 1.6)2921.3 (1.1, 1.5)0.58 Cannabis21241.7 (1.6, 1.8)8231.3 (1.1, 1.4)2661.0 (0.8, 1.2)\<0.001 Cocaine3280.4 (0.3, 0.5)1380.4 (0.3, 0.5)810.4 (0.3, 0.6)0.94 Heroin2550.2 (0.2, 0.3)1070.2 (0.1, 0.2)590.2 (0.2, 0.3)0.58 Opioid analgesics7620.8 (0.7, 0.9)3110.7 (0.6, 0.9)1750.8 (0.6, 1.0)0.76 Hallucinogens1450.1 (0.1, 0.1)530.1 (0.1, 0.1)190.0 (0.0, 0.1)0.07 Tranquilizers/sedatives1830.2 (0.1, 0.2)1100.2 (0.2, 0.3)620.2 (0.2, 0.4)0.25 Stimulants1870.2 (0.1, 0.3)960.2 (0.1, 0.2)430.2 (0.1, 0.3)0.84[^4]

[Table 3](#t0015){ref-type="table"} presents results from the multivariable logistic regression model with past-year drug use as the outcome variable for adults with medical multimorbidity (n = 13,575). Results from the adjusted model suggest that among adults with multimorbidity, odds of past-year drug use decreased with increasing age (AOR 0.17 for adults ≥65, AOR 0.46 for adults 50--64, and AOR 0.57 for adults 35--49, all *p* \< 0.001 with adults 18--34 as the comparison) and for females (AOR 0.52, *p* \< 0.001). For race/ethnicity, compared to whites non-Hispanic African Americans (AOR 0.71, *p* \< 0.05) and Asians (AOR 0.48, *p* \< 0.05) also had lower odds for past-year drug use. For family income, compared to incomes \<\$20,000, higher incomes (AOR 0.53 for incomes ≥\$75,000/year, *p* \< 0.001; AOR 0.64 for incomes \$50,000--\$74,999, *p* \< 0.01; AOR 0.62 for incomes \$20,000--\$49,999, *p* \< 0.001) were associated with lower odds for past-year drug use. In contrast, respondents reporting past-month use of tobacco (AOR 2.45, *p* \< 0.001), alcohol use (not meeting criteria for dependence) (AOR 3.33, *p* \< 0.001), alcohol dependence (AOR 10.19, *p* \< 0.001), past-year major depressive episode (AOR 1.28, *p* \< 0.05), and received mental health treatment in the past year (AOR 1.79, *p* \< 0.001) all had higher odds of reporting past-year drug use.Table 3Correlates of past-year substance use among adults with medical multimorbidity[a](#tf0025){ref-type="table-fn"} -- United States 2012--2014.Table 3CharacteristicOR(95% CI)AOR(95% CI)Age group 18--341.001.00 35--490.39[‖](#tf0045){ref-type="table-fn"}(0.34, 0.44)0.57[‖](#tf0045){ref-type="table-fn"}(0.48, 0.69) 50--640.25[‖](#tf0045){ref-type="table-fn"}(0.21, 0.29)0.46[‖](#tf0045){ref-type="table-fn"}(0.37, 0.57) ≥650.06[‖](#tf0045){ref-type="table-fn"}(0.04, 0.08)0.17[‖](#tf0045){ref-type="table-fn"}(0.11, 0.25)Sex Male1.001.00 Female0.68[‖](#tf0045){ref-type="table-fn"}(0.60, 0.77)0.52[‖](#tf0045){ref-type="table-fn"}(0.45, 0.61)Race/ethnicity Non-Hispanic White1.001.00 Non-Hispanic African American0.85(0.69, 1.06)0.71[‡](#tf0035){ref-type="table-fn"}(0.55, 0.92) Hispanic1.21(0.94, 1.55)0.94(0.70, 1.26) Non-Hispanic Asian0.38[§](#tf0040){ref-type="table-fn"}(0.22, 0.66)0.48[‡](#tf0035){ref-type="table-fn"}(0.26, 0.88) Other1.54[‡](#tf0035){ref-type="table-fn"}(1.08, 2.18)1.12(0.70, 1.81)Education \<High school1.001.00 High school0.86(0.68, 1.09)0.81(0.61, 1.09) Some college1.13(0.93, 1.38)1.08(0.83, 1.41) College or more0.81(0.65, 1.01)1.08(0.81, 1.44)Total family income \<\$20,0001.001.00 \$20,000--\$49,9990.57[‖](#tf0045){ref-type="table-fn"}(0.48, 0.67)0.62[‖](#tf0045){ref-type="table-fn"}(0.50, 0.76) \$50,000--\$74,9990.60[§](#tf0040){ref-type="table-fn"}(0.45, 0.80)0.64[§](#tf0040){ref-type="table-fn"}(0.47, 0.88) ≥\$75,0000.47[‖](#tf0045){ref-type="table-fn"}(0.36, 0.61)0.45[‖](#tf0045){ref-type="table-fn"}(0.32, 0.63)Marital status Never married1.001.00 Widowed0.13[‖](#tf0045){ref-type="table-fn"}(0.09, 0.19)0.57[‡](#tf0035){ref-type="table-fn"}(0.33, 0.98) Divorced or separated0.50[‖](#tf0045){ref-type="table-fn"}(0.41, 0.60)0.80(0.62, 1.04) Married0.23[‖](#tf0045){ref-type="table-fn"}(0.20, 0.27)0.49[‖](#tf0045){ref-type="table-fn"}(0.39, 0.62)Tobacco use Past month use4.57[‖](#tf0045){ref-type="table-fn"}(3.95, 5.29)2.45[‖](#tf0045){ref-type="table-fn"}(2.05, 2.92)Alcohol use Past year alcohol use, but not dependence3.96[‖](#tf0045){ref-type="table-fn"}(3.21, 4.90)3.33[‖](#tf0045){ref-type="table-fn"}(2.62, 4.23) Past year dependence22.98[‖](#tf0045){ref-type="table-fn"}(17.26, 30.59)10.19[‖](#tf0045){ref-type="table-fn"}(6.96, 14.94)Overall health Fair/poor1.001.00 Good0.86(0.71, 1.04)0.97(0.65, 1.46) Very good0.85(0.71, 1.03)0.97(0.76, 1.23) Excellent0.89(0.65, 1.21)0.97(0.77, 1.22)Mental health Past year major depressive episode[b](#tf0030){ref-type="table-fn"}2.94[‖](#tf0045){ref-type="table-fn"}(2.49, 3.47)1.28[‡](#tf0035){ref-type="table-fn"}(1.02, 1.61) Past year anxiety2.78[‖](#tf0045){ref-type="table-fn"}(2.39, 3.24)1.22(0.95, 1.58) Received mental health treatment in past year2.48[‖](#tf0045){ref-type="table-fn"}(2.13, 2.90)1.79[‖](#tf0045){ref-type="table-fn"}(1.40, 2.30)[^5][^6][^7][^8][^9]

4. Discussion {#s0035}
=============

In this large, nationally representative survey, we estimated the prevalence of past-year drug use among adults without chronic medical conditions and among those with one and two or more chronic medical conditions (i.e., medical multimorbidity). While the prevalence of past-year drug use was lower among adults with medical multimorbidity, compared to adults with no chronic conditions, nearly 12% of adults with multimorbidity reported engaging in past-year drug use. The lower prevalence of drug use among adults with multimorbidity may be due to both the fact that younger adults were more likely to engage in drug use and less likely to have chronic medical conditions, and some of those with multimorbidity may have stopped using drugs because of their morbidities ([@bb0095]). In alcohol studies for example, the "sick quitter" hypothesis proposes that adults may stop drinking due to medical illness, hospitalizations, or declining health, and therefore this group is not included as individuals with alcohol-related problems even though alcohol may have contributed to their illnesses ([@bb0155]). A similar phenomenon is likely occurring in observational studies with drug use including our study. However, we did find in multivariable models that among adults with medical multimorbidity, adults with alcohol dependence, current tobacco use, and adults with mental health problems were more likely to have engaged in past year drug use, and therefore be at particularly high risk for adverse effects of drug use. This emphasizes the importance of including SUDs and polysubstance use disorders to the multimorbidity framework as a distinct clinical profile that necessitates further research to better care for patients with complex multimorbid disease ([@bb0015]; [@bb0115]).

The intersection of substance use and medical multimorbidity is complex. Drug use has a wide array of physiologic effects on the body, that may negatively impact existing chronic medical disease and complicate its management. For example, cocaine use can impact both the cardiovascular and cerebrovascular systems that can lead to stroke, disability or sudden death, particularly among adults with pre-existing disease ([@bb0035]). Second, substance use can also complicate the clinical management of existing chronic diseases. Studies have shown decreased adherence to antiretroviral therapy among adults with HIV who engage in active substance use ([@bb0140]), and poor medication adherence for adults with psychosis who used cannabis ([@bb0110]). This is particularly relevant for adults with medical multimorbidity, who often have complex medication schedules that demand careful monitoring and daily management. In addition, the complicated medical care that adults with medical multimorbidity face places them at risk for medication management mistakes as well as adverse drug effects and interactions ([@bb0150]). This emphasizes the importance of substance use screening for adults with chronic conditions. In addition, since many adults in SUD treatment often have fragmented primary care ([@bb0060]), it is also important for SUD treatment providers to screen and ensure medical comorbidities are being managed.

In our study sample, cannabis was the most commonly used drug among adults with chronic disease. This is not surprising since cannabis is the most common drug used in the NSDUH study sample and given more positive attitudes and policies related to cannabis use ([@bb0045]; [@bb0055]). Cannabis has been used and studied for medical treatment of chronic diseases including HIV, multiple sclerosis, chronic pain, seizure disorder, and other mental health disorders ([@bb0105]). Although this study cannot distinguish between medical use versus recreational use of cannabis, using cannabis for these types of conditions may partially explain its high prevalence use among adults with chronic disease (both self-medicated or prescribed in states where it is legal) ([@bb0105]). The risks of cannabis have not been well-documented, particularly among older adults with medical multimorbidity who may be at higher risk for negative cardiovascular, pulmonary, and cognitive effects of cannabis use ([@bb0065]). Further study is needed to better assess the benefits and risks of cannabis use for specific chronic diseases and overall use by adults with medical multimorbidity.

The statistically significant correlates of past-year drug use among adults with medical multimorbidity identified in this study include younger age, male sex, low family income (\<\$20,000), current tobacco use, alcohol use and alcohol dependence, having had a major depressive episode, and having received mental health treatment. The demographic findings are similar to the overall results of NSDUH among the general adult population for illegal drug use including cannabis, such as adults with younger age and male sex having higher rates of use ([@bb0175]). However, our results are novel in that they identify a potentially very high-risk population of adults with the combination of medical multimorbidity with polysubstance use (drug, alcohol, and/or tobacco use) and/or mental health disorders. The strong association we found with alcohol dependence with concurrent drug use among adults with medical multimorbidity is alarming. Unhealthy alcohol use itself can cause, exacerbate, and complicate the management of several chronic medical diseases ([@bb0125]), and therefore the combination of illegal drug use with alcohol use, especially if used concurrently, can be particularly dangerous for adults with existing chronic medical conditions. Further, the co-occurrence of substance use and SUD with mental health illnesses are well documented ([@bb0100]), and interventions for addressing patients with co-occurring conditions have been developed and studied ([@bb0040]). The added mental health comorbidity is particularly important as one recent study of 843,584 veterans in the VA system who had at least three visits to a mental health clinic found 30.6% had co-occurring psychiatric and SUDs ([@bb0015]). The added burden of polysubstance use along with mental health problems highlights the need for a syndemic framework for caring for patients with compound multimorbidity, where the focus is how multiple health conditions are adversely affected by behavioral, psychiatric, biological, and social conditions ([@bb0020]; [@bb0130]). The use of the syndemic framework can help identify intervention strategies to reduce harms and improve the management of chronic disease for adults with medical multimorbidity, polysubstance use, and mental health disorders. In practice, one approach using this framework could include the integration of primary care and chronic disease management into SUD and mental health treatment settings and vice-versa.

There are important limitations to this study. First, the NSDUH responses are based on self-report and thus are subject to both recall and social-desirability bias; although the survey attempts to limit the latter via ACASI ([@bb0175]). Second, the NSDUH does not assess when a respondent first experienced or was diagnosed with a chronic medical disease, but asks only for lifetime prevalence. Therefore, participants may have had a chronic medical condition years before being surveyed and that condition may have been resolved and not overlap with past-year drug use. However, most of the conditions queried (i.e., hypertension, sleep apnea, heart disease, cirrhosis, stroke) tend to be lifelong. In addition, while the specific chronic diseases chosen in the NSDUH study design were based on expert opinion of medical diseases that are often related to substance use ([@bb0175]), it does not include many chronic medical diseases that are often asked in clinical research and epidemiological studies to understand the burden of chronic disease in specific populations. It also does not specify "heart disease" further, thus this could include a wide range of cardiac diseases. Therefore, the generalizability of this study is limited to the specific chronic diseases asked of this study sample and how it was asked. Also, assessing DSM SUD criteria via surveys can also be limited as these are not full diagnostic interviews. Finally, our study classifies users of drugs if the individual used in the past-year and therefore does not distinguish between one-time use versus more frequent use, which may potentially have different risks and consequences. To help address this we did include substance use disorder in estimating substance use among adults with chronic diseases.

5. Conclusions {#s0040}
==============

This study estimates the use of drugs by adults with medical multimorbidity and highlights areas that need to be better explored. Adults with multimorbidity should be screened for substance use to identify and treat unhealthy use, which can impact chronic disease. Further study is needed to better delineate the risks and harms of specific drug use not only on individual chronic diseases, but on individuals who live with and manage multiple chronic conditions.
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[^1]: All percentages are weighted.

[^2]: Based on the Nicotine Dependence Syndrome Scale (NDSS).

[^3]: Based on the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition.

[^4]: All percentages are weighted.

[^5]: Multimorbidity defined as 2 or more of the following: asthma, bronchitis, cirrhosis of the liver, diabetes, heart disease, hepatitis, hypertension (high blood pressure), lung cancer, HIV/AIDS, sleep apnea, stroke, and ulcers.

[^6]: Based on the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition.

[^7]: *p* \< 0.05.

[^8]: *p* \< 0.01.

[^9]: *p* \< 0.001.
